Oakoff Investments highlights PepsiCo's undervaluation with a 21% potential price increase and a forward dividend yield close to 4%, supporting a Buy rating. The company’s strategic moves—SKU rationalization, price cuts, and supply chain improvements—are expected to drive volume recovery and margin growth. While GLP-1 weight-loss drugs pose a risk, PepsiCo's focus on single-serve products and portion control helps mitigate long-term volume threats. Investors should watch Q1 2026 earnings for signs of volume growth and margin trends, especially in Frito-Lay North America.
The SCHD ETF has returned just under 2% in the past month, outperforming the S&P 500 ETF (SPY) by nearly 1%. Year-to-date, about 30 SCHD holdings have more than doubled the returns of SPY, which has returned 9.8%. Additionally, 31 SCHD holdings are t...
The global sleep water enhancers market is projected to grow from $1.48 billion in 2026 to $2.32 billion by 2030, with a CAGR of 11.9%. This growth is driven by increasing prevalence of sleep disorders, consumer preference for non-pill sleep aids, an...
PepsiCo, a global leader in snacks and beverages, is currently trading near its 52-week low and offers a dividend yield of over 4%. Despite volume declines in North America due to pricing and consumer challenges, its international segments are drivin...
